EyeGene Inc. (KOSDAQ:185490)
South Korea
· Delayed Price · Currency is KRW 1,952.00
+2.00 (0.10%)
At close: Dec 5, 2025
EyeGene Revenue
EyeGene had revenue of 1.10B KRW in the quarter ending September 30, 2025, with 14.36% growth. This brings the company's revenue in the last twelve months to 4.10B, up 25.97% year-over-year. In the year 2024, EyeGene had annual revenue of 3.36B with 7.37% growth.
Revenue (ttm)
4.10B
Revenue Growth
+25.97%
P/S Ratio
12.86
Revenue / Employee
n/a
Employees
n/a
Market Cap
52.76B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 315.56T |
| SK hynix | 84.09T |
| LG Energy Solution | 23.98T |
| Samsung Biologics | 5,504.84B |
| Hyundai Motor Company | 186.04T |
| Doosan Enerbility | 16.79T |
| HD Hyundai Heavy Industries | 16.39T |
| KB Financial Group | 14.89T |